Pharma companies active on the Belgian market are required by law to notify a RIP (๐๐๐ฌ๐ฉ๐จ๐ง๐ฌ๐ข๐๐ฅ๐ ๐๐จ๐ซ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ฎ๐๐ฅ๐ข๐๐ข๐ญ๐ฒ) to the Belgian Health Authorities.
The RIP is responsible to oversee all promotional activities for the Belgian market. Unlike some people may think, the RIP is not only involved in the review and approval of promotional material. The RIP has also the responsibility to :
Establish an appropriate internal procedure
Ensure compliance of regulations on samples
Check compliance of regulations on premiums or advantages
Ensure compliant medical information to health care professionals and patients
Oversee the training of sales representatives
Verify the compliance of product information and their translations
ย
Additionally the RIP is very often someone familiar with the ethical codes of industry associations and advises the company on doโs and donโts when organizing events taking into account both ethical codes from industry and MDEON requirements.
Often the RIP has a double role and acts as a local compliance manager for the companies. In this case the RIP will also be in charge of for instance transfer of value notifications and compliance check of contracts with health care organisations and health care professionals.
๐๐ฑ๐๐๐ฅ๐ข๐ฌ, ๐ก๐๐ฏ๐ข๐ง๐ 4 ๐๐๐ซ๐ญ๐ข๐๐ข๐๐ ๐๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐๐ ๐๐๐๐ฌ ๐๐๐ง ๐๐ง๐ฌ๐ฎ๐ซ๐ ๐๐จ๐ง๐ญ๐ข๐ง๐ฎ๐จ๐ฎ๐ฌ ๐๐ฏ๐๐ข๐ฅ๐๐๐ข๐ฅ๐ข๐ญ๐ฒ ๐๐จ๐ซ ๐ญ๐ก๐ข๐ฌ ๐ซ๐จ๐ฅ๐.
๐๐ฅ๐๐๐ฌ๐ ๐๐จ๐ง๐ญ๐๐๐ญย ๐ฐ๐ข๐ฆ.๐ง๐๐๐ค๐๐๐ซ๐จ๐๐๐ค@๐๐ฑ๐ญ๐๐ฅ๐ข๐ฌ.๐๐จ๐ฆย ๐๐จ๐ซ ๐ฆ๐จ๐ซ๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง.
